Biostar Pharmaceuticals Overview
Biostar Pharmaceuticals (BSPM) has a P/E ratio of 0.0, below the sector sector average of 33.83.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, BSPM shows a P/E ratio of 0.0. That is below the sector sector average of 33.83. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 33.83. Biostar Pharmaceuticals is at 0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BSPM stacks up against individual peers as well.
Investors watch BSPM's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biostar Pharmaceuticals's latest reading is 0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Biostar Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 0.0) with ownership activity and broader fundamentals.
